Welcome to BioMarket Group!

Deals and alliances in genitourinary and gynecological diseases

Additional Information

Published Date Apr 1, 2006
Special Offer No
Pages 602
PDF Fact Sheet View Fact Sheet for the report Deals and alliances in genitourinary and gynecological diseases in PDF format.
Published on Date No
Format No
Publisher N/A
Product Line No
Full Title No

Availability: In stock

$2,495.00

Quick Overview

Identify the latest dealmaking trends in your field
Request free sample pages from Deals and alliances in genitourinary and gynecological diseases

Partneringdesk deals and alliances in genitourinary and gynecology diseases provides an in-depth view of deals and alliances announced in genitourinary and gynecology diseases between 2001 and 2006, in a clear and accessible PDF format.


Introduction

A diagrammatical and analytical summary of the deals and dealmakers in the therapy area over a five-year period.


Chapter 1: Deals by company

A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.


Chapter 2: Deals by development stage

A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.


Chapter 3: Deal type

Access deal information by type of transaction – see who is licensing or partnering and using what type of deal.


Chapter 4: Industry sector

Deal announcements sorted by industry sector. Choose from nine sectors.


Chapter 5: Top 25 company profiles

Summary profiles for the most active companies in the therapy area over the past five years, including contact details, business strategy, partnering strategy, R&D and history.


Chapter 6: Detailed listing of deals and alliances

A full index of all the deals announced between Jan 2001 and Mar 2006.


Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments, and links to the full deal in the deal listing at the rear of each report.

Request free sample pages from Deals and alliances in genitourinary and gynecological diseases

Other selected research from the 'Business Development' category:


Future Growth Strategies: Drivers of sustainable development within the biotech, specialty and major pharma sectors
This report examines the feasibility of blockbuster drug development as a foundation of major pharma growth and proposes alternatives to expansion through M&A, expounding the benefits of in-licensing and then networked growth. Learn More


Partnering Agreements with Sanofi-Aventis 2010
The Partnering Agreements with Sanofi-Aventis 2010 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Sanofi-Aventis Labs and its partnering interests and activities over the past five years.
Learn More

Other selected research from the 'Other' category:


Interstitial Cystitis - Few Treatments, Poor Outcome
Interstitial cystitis (IC) is considered a rare disorder and poor understanding of the underlying causes of the disorder have made diagnosis and management difficult. Moreover, this has impacted on the development of effective drugs for this disorderthere are few available treatments for IC and as a result, significant unmet needs exist. Learn More


Deals and alliances in musculoskeletal diseases
Identify the latest dealmaking trends in your field Learn More